Q wave and Non-Q wave myocardial infarction after thrombolysis
S Matetzky,
GI Barabash,
B Rabinowitz,
S Rath,
YH Zahav,
O Agranat,
E Kaplinsky,
and
H Hod
Heart Institute, Sheba Medical Center, Tel-Hashomer, Israel.
OBJECTIVES: We studied the clinical outcome of Q wave and non-Q wave infarction after thrombolytic therapy. BACKGROUND: Controversy exists over the clinical significance of Q waves after thrombolysis. METHODS: We studied postthrombolytic angiographic results and short- and long-term clinical outcome in 150 patients with acute myocardial infarction classified as Q wave and non-Q wave on the 24-h and discharge electrocardiograms (ECGs). The results from the two groups were then compared. RESULTS: Eighty percent of patients had a Q wave and 20% a non-Q wave infarction on the 24-h ECG. The latter patients had lower peak creatine kinase (CK) levels (p < 0.001), but the two groups did not differ significantly otherwise. In 18 patients with a Q wave infarction on the 24-h ECG, pathologic Q waves disappeared. However, in seven patients with a non-Q wave infarction on the 24-h ECG, pathologic Q waves appeared throughout the hospital period. Q wave regression was associated with lower peak CK levels (p < 0.001) and an improvement in left ventricular ejection fraction (p < 0.01). Thus, only 72% of patients had a Q wave and 28% a non-Q wave infarction on the discharge ECG. Patients with a non-Q wave infarction on the discharge ECG had higher patency of the infarct-related artery (p < 0.04), lower mean peak CK levels (p < 0.0001), a higher ejection fraction (p = 0.001) and a lower incidence of heart failure (p = 0.06) than patients with a Q wave infarction on the discharge ECG. Although the 2-year incidence of reinfarction and revascularization was higher in patients with a non-Q wave infarction on the discharge ECG (p < 0.05), 2-year mortality was lower (p = 0.08). CONCLUSIONS: Although the early postthrombolytic distinction between Q wave and non-Q wave infarction conveys no significant information, during the hospital period, non-Q wave infarction is associated with a smaller infarct area, improved left ventricular function and lower mortality.
This article has been cited by other articles:

|
 |

|
 |
 
A. Halkin, D. Fourey, A. Roth, V. Boyko, and S. Behar
Incidence and prognosis of non-Q-wave vs. Q-wave myocardial infarction following catheter-based reperfusion therapy
QJM,
June 1, 2009;
102(6):
401 - 406.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Thygesen, J. S. Alpert, H. D. White, and on behalf of the Joint ESC/ACCF/AHA/WHF Task Force
Universal Definition of Myocardial Infarction
J. Am. Coll. Cardiol.,
November 27, 2007;
50(22):
2173 - 2195.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Thygesen, J. S. Alpert, H. D. White, on behalf of the Joint ESC/ACCF/AHA/WHF Task Force, TASK FORCE MEMBERS: Chairpersons: Kristian Thygese, Biomarker Group: Allan S. Jaffe, Coordinator (USA), ECG Group: Bernard Chaitman, Co-ordinator (USA), P, Imaging Group: Richard Underwood, Coordinator (UK), Intervention Group: Jean-Pierre Bassand, Co-ordina, Clinical Investigation Group: Paul W. Armstrong, C, et al.
Universal Definition of Myocardial Infarction
Circulation,
November 27, 2007;
116(22):
2634 - 2653.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Task Force Members, K. Thygesen, J. S. Alpert, H. D. White, Biomarker Group, A. S. Jaffe, F. S. Apple, M. Galvani, H. A. Katus, L. K. Newby, et al.
Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction
Eur. Heart J.,
October 2, 2007;
28(20):
2525 - 2538.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. C. Moon, D. Perez De Arenaza, A. G. Elkington, A. K. Taneja, A. S. John, D. Wang, R. Janardhanan, R. Senior, A. Lahiri, P. A. Poole-Wilson, et al.
The pathologic basis of Q-wave and non-Q-wave myocardial infarction: A cardiovascular magnetic resonance study
J. Am. Coll. Cardiol.,
August 4, 2004;
44(3):
554 - 560.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Tomoda and N. Aoki
Pathophysiology of Early Coronary Angioplasty with Stenting on Non-Q-Wave vs Q-Wave Myocardial Infarction
Angiology,
October 1, 2001;
52(10):
671 - 679.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J Abdulla, B Brendorp, C Torp-Pedersen, L Kober, and on behalf of the TRACE study group
Does the electrocardiographic presence of Q waves influence the survival of patients with acute myocardial infarction?
Eur. Heart J.,
June 2, 2001;
22(12):
1008 - 1014.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. I. Furman, H. L. Dauerman, R. J. Goldberg, J. Yarzbeski, D. Lessard, and J. M. Gore
Twenty-two year (1975 to 1997) trends in the incidence, in-hospital and long-term case fatality rates from initial q-wave and non-q-wave myocardial infarction: a multi-hospital, community-wide perspective
J. Am. Coll. Cardiol.,
May 1, 2001;
37(6):
1571 - 1580.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A Al-Mohammad, M Y Norton, I R Mahy, J C Patel, A E Welch, P Mikecz, and S Walton
Can the surface electrocardiogram be used to predict myocardial viability?
Heart,
December 1, 1999;
82(6):
663 - 667.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. G. Goodman, A. Langer, A. M. Ross, N. M. Wildermann, A. Barbagelata, E. B. Sgarbossa, G. S. Wagner, C. B. Granger, R. M. Califf, E. J. Topol, et al.
Non–Q-Wave Versus Q-Wave Myocardial Infarction After Thrombolytic Therapy : Angiographic and Prognostic Insights From the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries–I Angiographic Substudy
Circulation,
February 10, 1998;
97(5):
444 - 450.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|